Metabolic Health: The Biomarkers That Tell the Bigger Story

Metabolic Health Is a Pattern

Metabolic health is often reduced to one number.

Blood glucose gets the attention. Body weight gets tracked. Cholesterol gets labeled high or low. A single laboratory result can quickly become the focus of an entire health strategy.

Human metabolism does not work that way.

Glucose regulation, insulin signaling, lipid metabolism, blood pressure, body composition and cardiovascular risk are interconnected. A change in one area can occur alongside changes in several others, sometimes long before a person notices a difference in how they feel.

That is why metabolic health is better evaluated as a pattern.

Clinical definitions of metabolic syndrome reflect this principle. Rather than relying on one biomarker, they consider a combination of elevated fasting glucose, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure and central adiposity.

Those measurements do not tell us everything about metabolic health, but they demonstrate an important idea:

The relationship among markers often tells us more than one isolated result.

Glucose Is Important, but It Is Only Part of the Picture

Glucose is one of the body's primary energy substrates.

After carbohydrate-containing food is digested, glucose enters the bloodstream. Insulin helps coordinate the movement and storage of that glucose across tissues.

Fasting glucose provides a snapshot of glucose concentration after a period without food. It is widely used because it is inexpensive, standardized and clinically useful.

But fasting glucose represents one moment.

The body works continuously to regulate blood glucose, which means a normal fasting measurement does not describe everything that happened during the previous day, week or month.

This is where other measurements become useful.

HbA1c Adds a Longer View

Hemoglobin A1c, commonly written HbA1c or A1c, provides information about glucose exposure over a longer period than a single fasting glucose measurement.

Because glucose binds to hemoglobin in red blood cells, the proportion of glycated hemoglobin can provide an estimate of longer-term glycemic exposure.

That makes HbA1c useful, but it should not be treated as interchangeable with fasting glucose.

Fasting glucose, HbA1c, oral glucose tolerance testing, post-meal glucose and continuous glucose monitoring examine glucose regulation from different perspectives.

Two people can therefore have the same fasting glucose while having different patterns of glucose regulation.

Context matters.

Insulin Can Add Information Glucose Alone Does Not Provide

The body can sometimes maintain glucose within a relatively narrow range by increasing insulin output.

That means glucose may remain relatively stable while the amount of insulin required to maintain it changes.

This is one reason insulin resistance receives so much attention in metabolic research.

Insulin resistance refers broadly to reduced responsiveness to insulin in insulin-sensitive tissues. The body may compensate by producing more insulin, at least for a period of time.

Fasting insulin can therefore add another piece of information when evaluating metabolic physiology, although its interpretation has limitations.

Unlike glucose or HbA1c, fasting insulin has less standardization across assays and laboratories. It should not be treated as a standalone diagnostic test.

Researchers also use calculated measures such as HOMA-IR and other insulin-resistance indices. These can be useful in research and certain clinical contexts, but they remain estimates rather than direct measurements of insulin sensitivity.

The important concept is simpler:

Glucose concentration and the amount of insulin required to regulate glucose are related, but they are not the same measurement.

Triglycerides and HDL Reveal Another Part of the Metabolic Picture

A standard lipid panel contains information that extends beyond LDL cholesterol.

Triglycerides are fats transported through the bloodstream. Their concentration can be influenced by energy balance, diet, alcohol intake, insulin sensitivity, genetics and other factors.

HDL cholesterol measures cholesterol carried within high-density lipoprotein particles.

The combination of elevated triglycerides and reduced HDL-C commonly appears in metabolic syndrome and insulin-resistant states. Both are included in established metabolic syndrome criteria.

Researchers have also studied the triglyceride-to-HDL cholesterol ratio as a simple surrogate marker associated with insulin resistance.

A 2024 systematic review evaluated 32 studies involving nearly 50,000 participants and found that the TG/HDL-C ratio can provide useful information as an indirect marker of insulin resistance. The relationship varied across populations, however, so the ratio should not be interpreted as a universal diagnostic cutoff.

Again, the pattern matters more than turning another ratio into a single definitive score.

ApoB Looks at Atherogenic Particle Burden

ApoB adds a different dimension to lipid assessment.

Apolipoprotein B is present on major atherogenic lipoprotein particles. Because each of these particles carries one ApoB molecule, measuring ApoB provides an estimate of the number of circulating atherogenic particles.

This is different from measuring the amount of cholesterol carried inside those particles.

That distinction matters because LDL cholesterol and particle number can sometimes be discordant.

A person can have an LDL-C value that appears relatively unremarkable while carrying a larger number of cholesterol-depleted atherogenic particles.

A 2024 National Lipid Association expert consensus concluded that ApoB can augment a standard lipid panel and that cardiovascular risk often aligns more closely with ApoB or non-HDL-C when those measurements are discordant with LDL-C.

A subsequent systematic review of discordance studies involving more than 590,000 participants likewise found ApoB to be a more accurate cardiovascular risk marker than LDL-C in the studies comparing the two.

That does not make LDL cholesterol irrelevant.

It demonstrates why looking at several related measurements can reveal information that one measurement alone may miss.

Blood Pressure Is Part of Metabolic Health Too

Blood pressure can seem separate from glucose and lipid metabolism, but it belongs in the broader cardiometabolic picture.

Elevated blood pressure is one of the established components of metabolic syndrome.

Its relationship with metabolic health is complex.

Insulin resistance, sympathetic nervous system activity, kidney function, vascular function, body composition, physical activity, sleep, genetics and other factors can all influence blood pressure.

That makes blood pressure valuable precisely because it measures something different from a blood test.

Laboratory data describe important parts of physiology. Blood pressure adds information about the cardiovascular system that cannot be inferred reliably from glucose or cholesterol alone.

Repeated measurements are also more informative than placing too much weight on one reading.

Body Composition Adds Context That Scale Weight Cannot

Body weight is easy to measure.

It is also incomplete.

Two people at the same body weight can have very different amounts of skeletal muscle, fat mass and visceral adipose tissue.

Where fat is stored matters as well.

Central and visceral adiposity are strongly connected to the metabolic syndrome framework, which is why waist circumference has remained part of consensus criteria.

This does not mean every person with higher body fat has poor metabolic health or that a lean appearance guarantees good metabolic health.

It means body composition provides context that scale weight alone cannot.

Changes in waist circumference, fat mass, lean mass and body weight can also help explain changes occurring elsewhere in a metabolic profile.

A "Normal" Result Does Not Always End the Investigation

Reference ranges are necessary.

They provide a standardized framework for identifying results that fall outside expected laboratory intervals.

But a reference interval does not turn every value inside it into the same physiological state.

Imagine someone whose fasting glucose, triglycerides, blood pressure and waist circumference have all gradually increased over several years while each individual measurement remains below a diagnostic threshold.

Looking at the most recent results in isolation may miss the direction of change.

Looking at the trend tells a different story.

This is one reason longitudinal data can be so valuable.

The question is not only:

"Is this result outside the reference range?"

It can also be:

"How has this measurement changed from this person's established baseline?"

Those are different questions.

Trends Can Be More Informative Than Snapshots

Biomarkers fluctuate.

Sleep, recent exercise, hydration, illness, food intake, alcohol, medications, laboratory timing and normal biological variation can influence results.

One unusual measurement therefore deserves context.

Repeated measurements allow a pattern to emerge.

Suppose triglycerides improve while waist circumference decreases and fasting glucose remains stable.

Or fasting glucose changes very little while fasting insulin, triglycerides and body composition change substantially.

Those patterns provide more information than any individual number.

This is also why testing without a consistent strategy can create noise.

If every laboratory panel measures different biomarkers under different conditions, comparison becomes more difficult.

A useful baseline establishes the measurements that matter. Follow-up testing can then evaluate whether those measurements are moving in a meaningful direction.

Metabolic Health and Cellular Energy Are Connected

Metabolic health ultimately reaches the cellular level.

Nutrients have to be absorbed, transported, stored and used. Glucose and fatty acids enter metabolic pathways that support ATP production, while hormones and signaling systems help regulate when those substrates are stored or mobilized.

NAD+ and NADH participate in many of the redox reactions involved in that process.

For a closer look at that biology, our article on NAD+ and cellular energy explains how NAD metabolism connects nutrient processing, mitochondrial function and cellular energy production.

There Is No Single Metabolic Health Score

The desire for one score is understandable.

One number is easy to track.

Human physiology is less cooperative.

Fasting glucose can provide useful information about glycemic regulation.

HbA1c adds a longer-term perspective.

Insulin can add context about the physiological effort involved in maintaining glucose.

Triglycerides and HDL provide information about lipid metabolism.

ApoB estimates atherogenic particle burden.

Blood pressure adds cardiovascular information.

Body composition adds structural and metabolic context.

No single one of those measurements replaces all the others.

Even metabolic syndrome itself is defined as a cluster of abnormalities rather than a single laboratory result.

The objective should not be to collect every biomarker available.

It should be to identify the measurements that answer the question being asked.

Start With the Question

Testing becomes more useful when it begins with an objective.

Someone focused on glucose regulation may need a different set of measurements from someone evaluating cardiovascular risk.

Someone trying to improve body composition may care about changes in lean mass and waist circumference alongside metabolic markers.

Someone training heavily may need to interpret those measurements in the context of exercise volume, recovery and nutrition.

This prevents biomarker testing from becoming a collection exercise.

More data does not automatically create more understanding.

The value comes from selecting relevant measurements, establishing a baseline and interpreting subsequent changes together.

Build a Baseline, Then Measure Change

A baseline creates a reference point.

That matters because population reference ranges and individual trends answer different questions.

The first tells us how a measurement compares with a defined reference population or clinical threshold.

The second tells us how that measurement is changing within the same person.

Both can be useful.

Once a baseline exists, follow-up testing can answer a much more practical question:

Did the strategy change the measurements we intended to change?

Nutrition, training, sleep, recovery, body composition and other interventions can then be evaluated against actual data rather than assumptions.

If the expected changes do not occur, the strategy can be reconsidered.

If they do occur, the trend can be followed.

That creates a feedback loop between measurement and action.

The Bigger Story

Metabolic health cannot be summarized by glucose alone, cholesterol alone or body weight alone.

It emerges from the interaction among several physiological systems.

Glucose and HbA1c describe different aspects of glycemic regulation. Insulin can provide additional metabolic context. Triglycerides and HDL contribute information about lipid metabolism. ApoB helps quantify atherogenic particle burden. Blood pressure provides cardiovascular information. Body composition helps explain the physical environment in which those systems operate.

The goal is not to find one perfect biomarker.

It is to understand how relevant measurements fit together and how they change over time.

That is when laboratory data becomes more useful.

Instead of asking whether one number is "good" or "bad," a better question is:

What story do the measurements tell together?